S. Srinivasan explains why FDCs or cocktail drugs are being banned in India, why India has one of the highest number of FDCs in its pharma market in the world, what the legal provisions around the manufacture of such drugs are, and how they can contribute to public health challenges like antimicrobial resistance.
